Литература

1. Ahluwalia A, Hurteau JA, Bigsby RM and Nephew KP. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.// Gynecol.

2. Ammanamanchi S, Kim SJ, Sun LZ and Brattain MG. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.// J. Biol. Chem., 1998, 273, pp. 16527-16534.

3. Antequera F and Bird AP. Number of CpG islands and genes in human and mouse.// Proc. Natl. Acad. Sci. USA, 1993, 90, pp. 11995-11999.

4. Antequera F, Boyes J and Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines.// Cell, 1990, 62, pp.

503-514.

5. Bakin AV and Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos.// Science, 1999, 283, pp. 387-390.

6. Barlow DP. Methylation and imprinting: from host defense to gene regulation?// Science, 1993, 260, pp. 309-310.

7. Baylin SB and Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics.// Trends Genet., 2000, 16, pp. 168-174.

8. Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia.// Adv. Cancer Res., 1998, 72,

141-196.

9. Baylin SB, Hoppener JW, de Bustros A, Steenbergh PH, Lips CJ and Nelkin BD. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.// Cancer Res., 1986, 46, pp. 2917-2922.

10. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB and Herman JG. Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis.// Proc. Natl. Acad. Sci. USA, 1998, 95, pp. 11891-11896.

11. Bestor TH and Tycko B. Creation of genomic methylation patterns.// Nat. Genet., 1996, 12, pp. 363-367.

12. Bestor TH. Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain.// EMBO J., 1992, 11, pp. 2611-2517.

13. Bird AP, Taggart MH, Nicholls RD and Higgs DR. Non-methylated CpG-rich islands at the human a-globin locus: Implications for evolution of the a-globin pseudogene.// EMBO J., 1987, 6, pp. 999-1004.

14. Bird AP. CpG-rich islands and the function of DNA methylation.// Nature, 1986, 321, pp. 209-213.

15. Bird AP. DNA methylation patterns and epigenetic memory.// Genes & Dev., 2002, 16, pp. 6-21.

16. Bird AP. Gene number, noise reduction and biological complexity.// Trends Genet., 1995, 11, pp. 94-100.

17. Boehm M and Bonifacino JS. Adaptins - the final recount.// Mol. Biol. Cell, 2001, 12, pp. 2907-2920.

18. Boehm M and Bonifacino JS. Genetic analyses of adaptin function from yeast to mammals.// Gene, 2002, 286, pp. 175-186.

19. Boggs BA, Cheung P, Heard E, Spector DL, Chinault AC and Allis CD. Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes.// Nat. Genet., 2002, 30, pp. 73-76.

20. Cappabianca L, Farina AR, Tacconelli A, Mantovani R, Gulino A and Mackay AR. Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site.// Exp. Cell Res., 2003, 286, pp. 209-218.

21. Carotti D, Funiciello S, Palitti F and Strom R. Influence of pre-existing methylation on the de novo activity of eukaryotic DNA methyltransferase.// Biochemistry, 1998, 37, pp. 1101-1108.

22. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L and Jaenisch R. DNA hypomethylation leads to elevated mutation rates.// Nature, 1998, 395, pp. 89­93.

23. Chuang LS, Ian HI, Koh TW, Ng HH, Xu G and Li BF. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.// Science, 1997, 277, pp.

24. Clark SJ, Harrison J, Paul CL and Frommer M. High sensitivity mapping of methylated cytosines.// Nucl. Acids Res., 1994, 22, pp. 2290-2297.

25. Costello JF, Friihwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Huang HJS, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK and Plass C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.// Nat

Genet., 2000, 25, 132-138.

26. Cote S, Sinnett D and Momparler RL. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.// Anticancer Drugs, 1998,

9, pp. 743-759.

27. Cross SH, Charlton JA, Nan X and Bird AP. Purification of CpG islands using a methylated DNA binding column.// Nat. Genet., 1994, 6(3), pp. 236-244.

28. Dell'Angelica EC, Ooi CE and Bonifacino JS. p3A-adaptin, a subunit of the adaptor-like complex AP-3.// J. Biol. Chem., 1997, 272(24), pp. 15078-15084.

29. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S and Pelicci PG. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.// Science, 2002, 295, pp. 1079-1082.

30. Eng C, Herman JG and Baylin SB. A bird's eye view of global methylation.//

Nat. Genet., 2000, 24, pp. 101-102.

31. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB and Herman JG. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.// Am. J. Pathol., 1999, 155, pp. 1767-1772.

32. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB and Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.// Cancer Res., 1998, 58, pp. 4515-4518.

33. Esteller M, Hamilton SR, Burger PC, Baylin SB and Herman JG.

34. Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, Baylin SB and Herman JG. Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.// Cancer Res., 2001, 61, pp. 4689-4692.

35. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB and Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.// Cancer Res., 2000, 60, pp. 2368-2371.

36. Finnegan EJ, Peacock WJ and Dennis ES. DNA methylation, a key regulator of plant development and other processes.// Curr. Opin. Genet. Dev., 2000, 10, pp. 217-223.

37. Floyd S and De Camilli P. Endocytosis proteins and cancer: a potential link?// Trends Cell Biol., 1998, 8, pp. 299-301.

38. Gabriels J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D and Belayew A. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element.// Gene, 1999, 236, 25-32.

39. Gacy AM, Goellner G, Juranic N, Macura S and McMurray CT. Trinucleotide repeats that expand in human disease form hairpin structures in vitro.// Cell, 1995, 81, pp. 533-540.

40. Gardiner-Gardner M and Frommer M. CpG islands in vertebrate genomes.// J. Mol. Biol., 1987, 196, pp. 261-282.

41. van Geel M, Dickson MC, Beck AF, Bolland DJ, Frants RR, van der Maarel SM, de Jong PJ and Hewitt JE. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.// Genomics, 2002, 79, pp. 210­217.

42.

43. Gowher H, Leismann O and Jeltsch A. DNA of Drosophila melanogaster contains 5-methylcytosine.// EMBO J, 2000, 19, pp. 6918-6923.

44. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.// Cancer Res., 1995, 55, pp. 5195-5199.

45. Cui H, Horon IL, Ohlsson R, Hamilton SR and Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.// Nat. Med., 1998, 4, pp. 1276-1280.

46. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.// Proc. Natl. Acad. Sci. USA, 1996, 93, pp.9821-9826.

47. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM and Baylin SB. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.// Proc. Natl. Acad. Sci. USA, 1994, 91, pp. 9700-9704.

48. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.// Proc. Natl. Acad. Sci. USA, 1998, 95, pp. 6870-6875.

49. Herman JG. Hypermethylation of tumor suppressor genes in cancer.// Sem. Cancer Biol., 1999, 9, pp. 359-367.

50. Howell CY, Steptoes AL, Miller MW and Chaillet JR. cis-Acting signal for inheritance of imprinted DNA methylation patterns in the preimplantation mouse embryo.// Mol Cell Biol, 1998, 18, pp. 4149-4156.

51. Hsieh CL. Dynamics of DNA methylation pattern.// Curr.

52. Hsieh CL. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmat3b.// Mol. Cell. Biol., 1999, 19, pp. 8211-8218.

53. Hung MS, Karthikeyan N, Huang B, Koo HC, Kiger J, and Shen CJ. Drosophila proteins related to vertebrate DNA (5-cytosine) methyltransferases.// Proc. Natl. Acad. Sci., 1999, 96, pp. 11940-11945.

54. Iguchi-Ariga SM and Schaffner W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation.// Genes Dev., 1989, 3, pp. 612-619.

55. Jaenisch R and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and enviromental signals.// Nature Gen., 2003, 33,

pp. 245-254.

56. Janvier K, Craig H, Le Gall S, Benarous R, Guatelli J, Schwartz O and Benichou S. Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP.// J. Virol., 2001, 75, pp. 3971-3976.

57. Jones PA and Laird PW. Cancer epigenetics comes of age.// Nature Genet., 1999, 21, pp. 163-167.

58. Kafri T, Ariel M, Brandeis M, Shemer R, Urven L, McCarrey J, Cedar H and Razin A. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line.// Genes & Dev., 1992, 6, pp. 705-714.

59. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA and Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithlial cells.// Nature, 1998, 396, pp. 84-88.

60. Kohno T, Kawanishi M, Inazawa J and Yokota J. Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method.// Hum. Genet., 1998, 102, pp. 258-264.

61. Kondo Y and Issa JP. Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells.// J. Biol. Chem., 2003, in press.

62. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR and Stefansson K. A high-resolution recombination map of the human genome.// Nat. Genet., 2002, 31, pp. 241-247.

63. Laird PW and Jaenisch R. DNA methylation and cancer.// Hum. Mol. Genet., 1994, Vol. 3, pp. 1487 - 1495.

64. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL,

Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M,

Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L,

Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE,

Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI,

Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A,

Wetterstrand KA, Patrinos A, Morgan MJ, Szustakowki J, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome.// Nature, 2001, 409, pp. 860-921.

65. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh

WS, Isaacs WB, Nelson WG. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.// Proc. Natl. Acad. Sci. USA, 1994, 91, pp. 11733-11737.

66. Li E, Bestor TH and Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.// Cell, 1992, 69, pp. 915­926.

67. Li Q, Ahuja N, Burger PC and Issa JP. Methylation and silencing of the Thrombospondin-1 promoter in human cancer.// Oncogene, 1999, 18, pp. 3284­3289.

68. Liang G, Robertson KD, Talmadge C, Sumegi J and Jones PA. The gene for a novel transmembrane protein containing epidermal growth factor and follistain domains is frequently hypermethylated in human tumor cells.// Cancer Res.,

2000, 60, pp. 4907-4912.

69. Liang G, Salem CE, Yu MC, Nguyen HD, Gonzales FA, Nguyen TT, Nichols PW and Jones PA. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.// Genomics, 1998, 53, pp. 260-268.

70. Lindsay S and Bird AP. Use of restriction enzymes to detect potential gene sequences in mammalian DNA.// Nature, 1987, 327, pp. 336-338.

71. Lisitsyn N, Lisitsyn N and Wigler M. Cloning the differences between two complex genomes.// Science, 1993, 259, pp. 946-951.

72. Liu Y, Oakeley EJ, Sun L and Jost JP. Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci.// Nucleic Acids Res., 1998, 26, pp. 1038-1045.

73. Lyko F, Ramsahoye BH and Jaenisch R. DNA methylation in Drosophila melanogaster.// Nature, 2000, 408, pp. 538-540.

74. MacLeod AR, Rouleau J and Szyf M. Regulation of DNA methylation by the Ras signaling pathway.// J. Biol. Chem., 1995, 270, pp. 11327-11337.

75. Macleod D, Charlton J, Mullins J and Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.// Genes Devel., 1994, 8, pp. 2282-2292.

76. Maloisel L and Rossignol JL. Suppression of crossing-over by DNA methylation in Ascobolus.// Genes Devel., 1998, 12, pp. 1381-1389.

77. Martienssen RA and Colot V. DNA methylation and epigenetic inheritance in plants and filamentous fungi.// Science, 2001, 293, pp. 1070-1074.

78. Mayer W, Niveleau A, Walter J, Fundele R and Haaf T. Demethylation of the zygotic paternal genome.// Nature, 2000, 403, pp. 501-502.

79. McKeon C, Ohkubo H, Pastan I and de Crombrugghe B. Unusual methylation pattern of the a 2(1) collagen gene.// Cell, 1982, 29, pp. 203-210.

80. Melvin AJ, McGurn ME, Bort SJ, Gibson C and Lewis DB. Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells.// Eur. J. Immunol., 1995, 25, pp. 426-430.

81. Mummaneni P, Walker KA, Bishop PL and Turker MS. Epigenetic gene inactivation induced by a cis-acting methylation center.// J. Biol. Chem., 1995,

270, pp. 788-792.

82. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G and Jones PA. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.// Cancer Res., 2002, 62, pp. 6456-6461.

83. Noyer-Weidner M and Trautner TA. in "DNA Methylation: Molecular Biology and Biological Significance"// Jost JP and Saluz HP eds, Basel: Birkhauster

Verlag, 1993, pp. 39-108.

84. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB and Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.// Proc. Natl. Acad. Sci. USA, 1999, 96, pp. 12754-12759.

85. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD and Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.// Oncogene, 1993, 8, pp. 1063-1067.

86. Okano M, Bell DW, Haber DA and Li E. DNA methylationtransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.// Cell, 1999, 99, pp. 247-257.

87. Okano M, Xie S and Li E. Cloning and characterization of a family of novel mammalian DNA(cytosine-5)-methyltransferases.// Nat. Genet., 1998, 19, pp.

219-220.

88. Olek A, Oswald J and Walter J. A modified and improved method for bisulphite based cytosine methylation analysis.// Nucl. Acids Res., 1996, 24,

pp. 5064-5066.

89. Oue N, Kuraoka K, Kuniyasu H, Yokozaki H, Wakikawa A, Matsusaki K and Yasui W. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.// Oncol. Rep., 2001, 8, pp. 1085-1089.

90. Peters AH, Mermoud JE, O'Carroll D, Pagani M, Schweizer D, Brockdorff N and Jenuwein T. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin.// Nat. Genet., 2002, 30, pp. 77-80.

91. Pfeifer GP. p53 mutational spectra and the role of methylated CpG sequences.//

Mutat. Res., 2000, 450, pp. 155-66.

92. Pogribny IP, Poirier LA and James SJ. Differential sensitivity to loss of cytosine methyl groups within the hepatic p53 gene of folate/methyl deficient rats.// Carcinogenesis, 1995, 16, pp. 2863-2867.

93. Pradhan S and Kim GD. The retinoblastoma gene product interacts with maintenance human DNA(cytosine-5)-methyltransferase and modulates it activity.// EMBO J., 2002, 21, pp. 779-788.

94. Rainier S and Feinberg AP. Capture and characterization of 5-aza-2'-deoxycytidine-treated C3H/10T1/2 cells prior to transformation.// Proc. Natl. Acad. Sci. USA, 1988, 85, pp. 6384-6388.

95. Rapoport I, Chen YC, Cupers P, Shoelson SE and Kirchhausen T. Dileucine-based sorting signals bind to the beta chain of AP-1 at a site distinct and regulated differently from the tyrosine-based motif-binding site.// EMBO J., 1998, 17, pp. 2148-2155.

96. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H,

Feinberg AP, Lengauer C, Kinzier KW, Baylin SB and Vogelstein B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.// Nature, 2002,

416, pp. 552-556.

97. Riggs AD, Xiong Z, Wang L and LeBon JM. Methylation dynamics, epigenetic fidelity and X chromosome structure.// Novartis Found. Symp., 1998, 214, pp. 214-225.

98. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA and Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.// Nucl. Acids Res., 1999, 27, pp. 2291-2298.

99. Robinson MS and Bonifacino JS. Adaptor-related proteins.// Curr. Opin. Cell Biol, 2001, 13, pp. 444-453.

100. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H and Hirohashi S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.// Hepatology, 2001, 33, pp. 561-568.

101. Sasaki H, Allen ND and Surani MA. in "DNA methylation: Molecular Biology and Biological Significance"// Jost JP and Saluz HP eds, Basel: Birkhauster

Verlag, 1993, pp. 469-486.

102. Shin TH, Paterson AJ, Grant JH 3rd, Meluch AA and Kudlow JE. 5-

Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression.// Mol. Cell Biol., 1992, 12, pp. 3998-4006.

103. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN and Farreli WE. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.// Cancer Res., 2000, 60, pp. 1211-1216.

104. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.// Nature, 2001, 409, pp. 207-211.

105. Szyf M, Tanigawa G and McCarthy Jr PL. A DNA signal from Thy-1 defines de novo methylation patterns in embryonic stem cells.// Mol. Cell. Biol., 1990, 10, pp. 4396-4400.

106. Takai D and Jones PA. Comprehensive analysis of CpG islands in human

chromosomes 21 and 22.// Proc. Natl. Acad. Sci. USA, 2002, 99(6), pp. 3740­3745.

107. Takebayashi S, Nakao M, Fujita N, Sado T, Tanaka M, Taguchi H and Okumura K. 5-Aza-2'-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation.// Biochem. Biophys. Res. Commun., 2001, 288, pp. 921-926.

108. Toth M, Lichtenberg U and Doerfler W. Genomic sequencing reveals a 5-methylcytosine-free domain in active promoters and the spreading of preimposed methylation patterns.// Proc. Natl. Acad. Sci. USA, 1989, 86, pp.

3728-3732.

109. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin S and Issa

JP. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.// Cancer Res., 1999, 59, pp. 2307-2312.

110. Toyota M, Ho C, Ohe-Toyota M, Baylin S and Issa JP. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors.// Cancer Res., 1999, 59, pp. 4535-4541.

111. Turker MS, Mummaneni P and Bishop PL. Region and cell type-specific de novo DNA methylation in cultured mammalian cells.// Somat. Cell. Mol. Genet., 1991, 17, pp. 151-157.

112. Turker MS. The establishment and maintenance of DNA methylation patterns in mouse somatic cells.// Sem. Cancer Biol., 1999, 9, pp. 329-337.

113. Tweedie S, Ng HH, Barlow AL, Turner BM, Hendrich B and Bird AP. Vestiges of a DNA methylation system in Drosophila melanogaster.// Nat. Genet., 1999,

23, pp. 389-390.

114. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM,

Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB,

Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao

Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel

B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R,

Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor

S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke

C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H,

Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X. The sequence of the human genome.// Science, 2001, 291, pp. 1304-1351.

115. Vertino PM, Yen RW, Gao J and Baylin SB. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA(cytosine-5)-methyltransferase.// Mol. Cell. Biol., 1996, 16, pp. 4555-4565.

116. Vieira AV, Lamaze C and Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis.// Science, 1996, 274, pp. 2086-2089.

117. Warnecke PM, Mann JR, Frommer M and Clark SJ. Bisulfite sequencing in preimplantation embryos: DNA methylation profile of the upstream region of the mouse imprinted H19 gene.// Genomics, 1998, 51, pp. 182-190.

118. Wigler M, Levy D and Perucho M. The somatic replication of DNA methylation.// Cell, 1981, 24, pp. 33-40.

119. Wolf P, Hu YC, Doffek K, Sidransky D and Ahrendt SA. O6-Methylguanine-

DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.// Cancer Res., 2001, 61, pp. 8113­8117.

120. Wong DJ, Foster SA, Galloway DA and Reid BJ. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest.// Mol. Cell Biol., 1999, 19, pp. 5642-5651.

121. Worm J and Guldberg P. DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.// J. Oral. Pathol. Med., 2002, 31,

pp. 443-449.

122. Yoder JA and Bestor TH. A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast.// Hum. Mol. Genet., 1998, 7, pp. 279-284.

123. Yoder JA, Soman NS, Verdine GL and Bestor TH. DNA(cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe.// J. Mol. Biol., 1997, 270, pp. 385-395.

124. Zhang YJ, Chen Y, Ahsan H, Lunn RM, Lee PH, Chen CJ and Santella RM.

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.// Int. J. Cancer, 2003, 103, pp. 440-444.

125. Домнинский ДА, Прокунина ЛВ, Козырев СВ, Будилов АВ, Полтараус АБ, Забаровский ЕР и Захарьев ВМ. Построение крупномасштабной физической карты генома человека. Характеристика NotI-клонов с короткой геномной вставкой.// Мол. Биол., 1999, 33, с. 533-541.

126. Клонирование ДНК. Методы.// под ред. Гловера Д. М.: Мир, 1988, стр.

140-175.

127. Лихтенштейн АВ и Киселева НП. Метилирование ДНК и канцерогенез.// Биохимия, 2001, 66, с. 235-255.

128. Маниатис Т, Фрич Э, Сэмбрук Дж. Методы генетической инженерии. Молекулярное клонирование. М.: Мир, 1984.- 480 с.

129. Ровенский ЮА. Клеточные и молекулярные механизмы опухолевой инвазии.// Биохимия, 1998, 63, с. 1204-1221.